T cells armed with anti-CD3 × anti-CD20 bispecific antibody enhance killing of CD20 + malignant B cells and bypass complement-mediated rituximab resistance in vitro
| Autor: | Gall, Jonathan M., Davol, Pamela A., Grabert, Ryan C., Deaver, Mark, Lum, Lawrence G. |
|---|---|
| Zdroj: | In Experimental Hematology 2005 33(4):452-459 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect